​

Funding Round

Series B - Eagle Genomics

Series B - Eagle Genomics

Investment Firm

Overview

Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.

Announced Date

Oct 31, 2022

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

Aberdeen Standard Investments

Aberdeen Standard Investments

No designation

Participant Investors

3

Investor Name
Participant InvestorGranpool Innovative Investments
Participant InvestorAberdeen Standard Investments
Participant InvestorETF Partners

Round Details and Background

Eagle Genomics raised $19772107 on 2022-10-31 in Series B

Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.

Company Funding History

13

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 07, 2016
Non Equity Assistance - Eagle Genomics
1-undefined
Nov 30, 2016
Venture Round - Eagle Genomics
3-1.3M
Nov 22, 2013
Seed Round - Eagle Genomics
3-665.2K
Sep 06, 2013
Seed Round - Eagle Genomics
5-1.6M

Recent Activity

There is no recent news or activity for this profile.